Our industry has been, and is expected to continue to be, subject to healthcare cost containment and drug pricing scrutiny by regulatory agencies in the U.S.

filing / Aug 3, 2026 / receipt

decrease our available cash resources, and we may not be able to generate sufficient cash to service our debt obligations which could, among other things, force us to raise additional funds and/or force us to reduce our expenses, either of which could have a material adverse effect on our business.

filing / Aug 3, 2026 / receipt

Johnson was appointed our Executive Vice President and CFO effective March 1, 2024. (10) Mr. Cozadd served as CEO until August 11, 2025, following which he served in a transition role through September 14, 2025 and subsequently retired on September 14, 2025.

filing / Jun 8, 2026 / receipt

, the executive’s authority, duties and responsibilities will be considered to be substantially reduced; (iv) a reduction in the executive’s title; or (v) a substantial increase in executive’s required business travel as compared with the executive’s required business travel prior to the CIC.

filing / Jun 8, 2026 / receipt

will be considered to be substantially reduced; (iv) a reduction in the executive’s title; or (v) a substantial increase in executive’s required business travel as compared with the executive’s required business travel prior to the CIC.

filing / Jun 8, 2026 / receipt

Johnson was appointed our Executive Vice President and CFO as of March 2024. From January 2018 to February 2024, Mr. Johnson served as group vice president and treasurer at Eli Lilly and Company, a global pharmaceutical company.

filing / Jun 8, 2026 / receipt

This process, which is commonly referred to as “householding” potentially means extra convenience for shareholders and cost savings for companies.

filing / Jun 8, 2026 / receipt